REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc., trading under the ticker TZAC, is the post-combination entity formed through the merger of Tenzing Acquisition Corp, a blank check company that completed its IPO in 2020, with Reviva Pharmaceuticals, a clinical-stage biopharmaceutical company focused on neurological and psychiatric disorders. The SPAC was sponsored by Tenzing Capital. The company filed an 8-K with the SEC on December 18, 2020, under accession number 0001104659-20-137506, reflecting activity during the transaction process in the healthcare and life sciences sector. For complete filing history, sponsor details, and deal metrics on TZAC and hundreds of other SPACs, sign up for full data access at SpacDesk.